Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate.

作者: Jill A. Macoska , Isaac J. Powell , Wael Sakr , Mary-Ann Lane

DOI: 10.1016/S0022-5347(17)37504-3

关键词:

摘要: Genetic alterations of multiple loci that serve as markers for the induction and progression disease have been identified in several adenocarcinomas, but not adenocarcinoma prostate. To determine if similar genetic occur prostate carcinoma could extent clinical disease, we examined 23 predominantly moderately-differentiated, localized carcinomas one prostatic dysplasia changes structure copy number ten selected genes. These genes include 1) those important to androgen metabolism prostate, receptor steroid 5 alpha reductase genes; 2) map 10q (PLAU) 7q (MET) chromosomal regions found deleted some carcinomas, 3) proto-oncogenes (ERBB2, INT2, MYC) tumor suppressor gene (RB1, TP53 D17S5) altered adenocarcinomas breast, colon lung. Gene were detected specimen, a lymph node metastasis from poorly differentiated tumor. This specimen exhibited loss heterozygosity two putatively active suppression, D17S5, on short arm chromosome 17. study indicates gross evident be used development well- or lesions, 17p region may useful marker advanced

参考文章(31)
T Mitsudomi, S Piantadosi, M M Nau, D T Curiel, I Chiba, D L Buchhagen, H Koga, T Takahashi, D D'Amico, D Carbone, Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene. ,vol. 5, pp. 1603- 1610 ,(1990)
M van de Vijver, R van de Bersselaar, P Devilee, C Cornelisse, J Peterse, R Nusse, Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Molecular and Cellular Biology. ,vol. 7, pp. 2019- 2023 ,(1987) , 10.1128/MCB.7.5.2019
B. S. Carter, C. M. Ewing, W. S. Ward, B. F. Treiger, T. W. Aalders, J. A. Schalken, J. I. Epstein, W. B. Isaacs, Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 8751- 8755 ,(1990) , 10.1073/PNAS.87.22.8751
P.J. McAlpine, T.B. Shows, C. Boucheix, L.C. Stranc, T.G. Berent, A.J. Pakstis, R.C. Douté, Report of the nomenclature committee and the 1989 catalog of mapped genes. Cytogenetic and Genome Research. ,vol. 51, pp. 13- 66 ,(1989) , 10.1159/000132780
M. Park, M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, G. Vande Woude, Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 6379- 6383 ,(1987) , 10.1073/PNAS.84.18.6379
P. Verde, M. P. Stoppelli, P. Galeffi, P. Di Nocera, F. Blasi, Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 4727- 4731 ,(1984) , 10.1073/PNAS.81.15.4727
Andrew P. Feinberg, Bert Vogelstein, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity Analytical Biochemistry. ,vol. 132, pp. 6- 13 ,(1983) , 10.1016/0003-2697(83)90418-9
J. R W Yates, Human Gene Mapping 10. Journal of Medical Genetics. ,vol. 27, pp. 343- 343 ,(1990) , 10.1136/JMG.27.5.343-A
Rosemary Watt, Lawrence W. Stanton, Kenneth B. Marcu, Robert C. Gallo, Carlo M. Croce, Giovanni Rovera, Nucleotide sequence of cloned cDNA of human c- myc oncogene Nature. ,vol. 303, pp. 725- 728 ,(1983) , 10.1038/303725A0
S. Andersson, D. W. Russell, Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 3640- 3644 ,(1990) , 10.1073/PNAS.87.10.3640